|
|
| G
|
Ambp
|
alpha-1-microglobulin/bikunin precursor
|
affects binding
|
ISO
|
1-anilino-8-naphthalenesulfonate binds to AMBP protein
|
CTD |
PMID:16461020 |
|
NCBI chr 5:81,583,621...81,593,938
Ensembl chr 5:81,583,622...81,593,850
|
|
| G
|
Apod
|
apolipoprotein D
|
affects binding
|
ISO
|
1-anilino-8-naphthalenesulfonate binds to APOD protein
|
CTD |
PMID:16461020 |
|
NCBI chr11:82,936,216...82,957,264
Ensembl chr11:82,936,038...82,957,263
|
|
| G
|
C8g
|
complement C8 gamma chain
|
affects binding
|
ISO
|
1-anilino-8-naphthalenesulfonate binds to C8G protein
|
CTD |
PMID:16461020 |
|
NCBI chr 3:28,718,648...28,720,232
|
|
| G
|
Gsta1
|
glutathione S-transferase alpha 1
|
affects binding
|
ISO
|
1-anilino-8-naphthalenesulfonate binds to GSTA1 protein
|
CTD |
PMID:14690442 |
|
NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528
|
|
| G
|
Lcn1
|
lipocalin 1
|
affects binding
|
ISO
|
1-anilino-8-naphthalenesulfonate binds to LCN1 protein
|
CTD |
PMID:16461020 |
|
NCBI chr 3:29,930,943...29,935,418
|
|
| G
|
Lcn2
|
lipocalin 2
|
affects binding
|
ISO
|
1-anilino-8-naphthalenesulfonate binds to LCN2 protein
|
CTD |
PMID:16461020 |
|
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842
|
|
| G
|
Obp2a
|
odorant binding protein 2A
|
affects binding
|
ISO
|
1-anilino-8-naphthalenesulfonate binds to OBP2A protein
|
CTD |
PMID:16461020 |
|
NCBI chr 3:28,904,024...28,907,391
Ensembl chr 3:28,902,876...28,907,389
|
|
| G
|
Orm1
|
orosomucoid 1
|
affects binding
|
ISO
|
1-anilino-8-naphthalenesulfonate binds to ORM1 protein
|
CTD |
PMID:16461020 |
|
NCBI chr 5:81,788,509...81,791,661
Ensembl chr 5:81,788,395...81,791,667
|
|
| G
|
Paep
|
progestagen associated endometrial protein
|
affects binding
|
ISO
|
1-anilino-8-naphthalenesulfonate binds to PAEP protein
|
CTD |
PMID:16461020 |
|
NCBI chr 3:28,929,252...28,932,592
|
|
| G
|
Ptgds
|
prostaglandin D2 synthase
|
affects binding
|
ISO
|
1-anilino-8-naphthalenesulfonate binds to PTGDS protein
|
CTD |
PMID:16461020 |
|
NCBI chr 3:28,680,044...28,682,978
Ensembl chr 3:28,680,044...28,682,978
|
|
| G
|
Ttr
|
transthyretin
|
affects binding multiple interactions
|
ISO
|
1-anilino-8-naphthalenesulfonate binds to TTR protein 3,3'-dichlorobiphenyl metabolite inhibits the reaction [1-anilino-8-naphthalenesulfonate binds to TTR protein]; 3,4-dichlorinated biphenyl metabolite inhibits the reaction [1-anilino-8-naphthalenesulfonate binds to TTR protein]; 4-chlorobiphenyl metabolite inhibits the reaction [1-anilino-8-naphthalenesulfonate binds to TTR protein]; Thyroxine inhibits the reaction [1-anilino-8-naphthalenesulfonate binds to TTR protein]
|
CTD |
PMID:23584369 |
|
NCBI chr18:12,216,684...12,225,972
Ensembl chr18:12,216,732...12,225,969
|
|
|
|
| G
|
Cat
|
catalase
|
decreases activity
|
ISO
|
Chlortetracycline results in decreased activity of CAT protein
|
CTD |
PMID:30768968 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
multiple interactions
|
ISO
|
Chlortetracycline inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
|
CTD |
PMID:23769903 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions
|
ISO EXP
|
Filipin inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein] Filipin inhibits the reaction [ferrous sulfate results in increased phosphorylation of AKT1 protein]; Filipin inhibits the reaction [Iron results in increased phosphorylation of AKT1 protein]
|
CTD |
PMID:12614848 PMID:17172471 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Chuk
|
component of inhibitor of nuclear factor kappa B kinase complex
|
multiple interactions
|
EXP
|
Filipin inhibits the reaction [ferrous sulfate results in increased activity of [CHUK protein binds to IKBKB protein]]; Filipin inhibits the reaction [Iron results in increased activity of [CHUK protein binds to IKBKB protein]]
|
CTD |
PMID:17172471 |
|
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:252,908,749...252,944,273
|
|
| G
|
Cybb
|
cytochrome b-245 beta chain
|
multiple interactions
|
ISO
|
Filipin inhibits the reaction [Homocysteine affects the localization of CYBB protein]
|
CTD |
PMID:20036696 |
|
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
multiple interactions
|
ISO
|
[Filipin co-treated with Chlorpromazine co-treated with Wortmannin] inhibits the reaction [Particulate Matter results in increased expression of CYP1A1 mRNA]
|
CTD |
PMID:29724254 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
multiple interactions
|
ISO
|
[Filipin co-treated with Chlorpromazine co-treated with Wortmannin] inhibits the reaction [Particulate Matter results in increased expression of CYP1B1 mRNA]
|
CTD |
PMID:29724254 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
| G
|
Des
|
desmin
|
multiple interactions
|
ISO
|
Filipin inhibits the reaction [Homocysteine results in increased expression of DES mRNA]; Filipin inhibits the reaction [Homocysteine results in increased expression of DES protein]
|
CTD |
PMID:20036696 |
|
NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:84,298,447...84,307,347
|
|
| G
|
Hspb1
|
heat shock protein family B (small) member 1
|
multiple interactions
|
ISO
|
Filipin inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of HSPB1 protein]
|
CTD |
PMID:21457723 |
|
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
multiple interactions
|
ISO
|
Filipin inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of ICAM1 protein]
|
CTD |
PMID:19632255 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Ikbkb
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
multiple interactions
|
EXP
|
Filipin inhibits the reaction [ferrous sulfate results in increased activity of [CHUK protein binds to IKBKB protein]]; Filipin inhibits the reaction [Iron results in increased activity of [CHUK protein binds to IKBKB protein]]
|
CTD |
PMID:17172471 |
|
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
|
|
| G
|
Jak1
|
Janus kinase 1
|
multiple interactions
|
ISO
|
Filipin inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased phosphorylation of JAK1 protein]
|
CTD |
PMID:19632255 |
|
NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:120,896,046...120,996,758
|
|
| G
|
Map2k6
|
mitogen-activated protein kinase kinase 6
|
multiple interactions
|
EXP
|
Filipin inhibits the reaction [ferrous sulfate promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]]; Filipin inhibits the reaction [ferrous sulfate results in increased phosphorylation of MAP2K6 protein]; Filipin inhibits the reaction [Iron promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]]; Filipin inhibits the reaction [Iron results in increased phosphorylation of MAP2K6 protein]
|
CTD |
PMID:17172471 |
|
NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721
|
|
| G
|
Map3k7
|
mitogen activated protein kinase kinase kinase 7
|
multiple interactions
|
EXP
|
Filipin inhibits the reaction [ferrous sulfate promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]]; Filipin inhibits the reaction [ferrous sulfate results in increased activity of MAP3K7 protein]; Filipin inhibits the reaction [Iron promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]]; Filipin inhibits the reaction [Iron results in increased activity of MAP3K7 protein]
|
CTD |
PMID:17172471 |
|
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions
|
EXP
|
Filipin inhibits the reaction [ferrous sulfate results in increased phosphorylation of MAPK1 protein]; Filipin inhibits the reaction [Iron results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:17172471 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions
|
EXP
|
Filipin inhibits the reaction [ferrous sulfate results in increased phosphorylation of MAPK3 protein]; Filipin inhibits the reaction [Iron results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:17172471 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Ncf1
|
neutrophil cytosolic factor 1
|
multiple interactions
|
ISO
|
Filipin inhibits the reaction [Homocysteine affects the localization of NCF1 protein]
|
CTD |
PMID:20036696 |
|
NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079
|
|
| G
|
Nphs1
|
NPHS1 adhesion molecule, nephrin
|
multiple interactions
|
ISO
|
Filipin inhibits the reaction [Homocysteine results in decreased expression of NPHS1 mRNA]; Filipin inhibits the reaction [Homocysteine results in decreased expression of NPHS1 protein]
|
CTD |
PMID:20036696 |
|
NCBI chr 1:94,848,261...94,876,522
Ensembl chr 1:94,848,261...94,876,521
|
|
| G
|
Nphs2
|
NPHS2 stomatin family member, podocin
|
multiple interactions
|
ISO
|
Filipin inhibits the reaction [Homocysteine results in decreased expression of NPHS2 mRNA]; Filipin inhibits the reaction [Homocysteine results in decreased expression of NPHS2 protein]
|
CTD |
PMID:20036696 |
|
NCBI chr13:70,993,622...71,011,585
Ensembl chr13:70,999,186...71,011,572
|
|
| G
|
Prnp
|
prion protein
|
increases secretion multiple interactions decreases expression
|
ISO
|
Filipin results in increased secretion of PRNP protein Filipin inhibits the reaction [Copper Sulfate results in increased uptake of and affects the localization of PRNP protein] [Copper co-treated with Filipin] results in increased cleavage of PRNP protein; Filipin inhibits the reaction [Copper Sulfate results in increased uptake of and affects the localization of PRNP protein] Filipin results in decreased expression of PRNP protein alternative form
|
CTD |
PMID:11994310 PMID:19597535 |
|
NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:139,630,144...139,658,436
|
|
| G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
multiple interactions
|
ISO
|
Filipin inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased phosphorylation of SRC protein]
|
CTD |
PMID:19632255 |
|
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
|
|
| G
|
Vcam1
|
vascular cell adhesion molecule 1
|
multiple interactions
|
ISO
|
Filipin inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of VCAM1 protein]
|
CTD |
PMID:19632255 |
|
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
|
|
|
|
| G
|
Abcb7
|
ATP binding cassette subfamily B member 7
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to ABCB7 protein
|
CTD |
PMID:27129696 |
|
NCBI chr X:73,361,296...73,502,464
Ensembl chr X:73,361,310...73,502,547
|
|
| G
|
Akr1c2
|
aldo-keto reductase family 1, member C2
|
increases expression
|
ISO
|
Fluorescein-5-isothiocyanate results in increased expression of AKR1C2 mRNA
|
CTD |
PMID:20491607 |
|
NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686
|
|
| G
|
Anxa4
|
annexin A4
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to ANXA4 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 4:120,741,750...120,798,534
Ensembl chr 4:120,741,750...120,798,513
|
|
| G
|
Arhgap6
|
Rho GTPase activating protein 6
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to ARHGAP6 protein
|
CTD |
PMID:27129696 |
|
NCBI chr X:28,525,912...29,062,344
Ensembl chr X:28,525,917...29,061,244
|
|
| G
|
Azi2
|
5-azacytidine induced 2
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to AZI2 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 8:126,651,268...126,674,795
Ensembl chr 8:126,651,206...126,676,182
|
|
| G
|
Capzb
|
capping actin protein of muscle Z-line subunit beta
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to CAPZB protein
|
CTD |
PMID:27129696 |
|
NCBI chr 5:156,718,619...156,818,623
Ensembl chr 5:156,650,432...156,818,619
|
|
| G
|
Cd109
|
CD109 molecule
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to CD109 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 8:88,334,736...88,449,463
Ensembl chr 8:88,334,736...88,449,462
|
|
| G
|
Cd180
|
CD180 molecule
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to CD180 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 2:35,589,889...35,602,837
Ensembl chr 2:35,589,451...35,603,982
|
|
| G
|
Cd86
|
CD86 molecule
|
increases expression
|
ISO
|
Fluorescein-5-isothiocyanate results in increased expression of CD86 protein
|
CTD |
PMID:19665512 |
|
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361
|
|
| G
|
Cd93
|
CD93 molecule
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to CD93 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 3:156,345,019...156,351,537
Ensembl chr 3:156,345,019...156,351,537
|
|
| G
|
Cdc20
|
cell division cycle 20
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to CDC20 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799
|
|
| G
|
Copa
|
COPI coat complex subunit alpha
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to COPA protein
|
CTD |
PMID:27129696 |
|
NCBI chr13:87,078,853...87,119,256
Ensembl chr13:87,078,383...87,119,256
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
increases expression
|
ISO
|
Fluorescein-5-isothiocyanate results in increased expression of CYP1A1 mRNA
|
CTD |
PMID:20491607 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Dcaf4
|
DDB1 and CUL4 associated factor 4
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to DCAF4 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 6:108,885,970...108,912,116
Ensembl chr 6:108,885,932...108,912,110
|
|
| G
|
Dot1l
|
DOT1 like histone lysine methyltransferase
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to DOT1L protein
|
CTD |
PMID:27129696 |
|
NCBI chr 7:9,569,439...9,607,095
Ensembl chr 7:9,569,439...9,607,095
|
|
| G
|
Elac1
|
elaC ribonuclease Z 1
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to ELAC1 protein
|
CTD |
PMID:27129696 |
|
NCBI chr18:69,596,475...69,617,206
Ensembl chr18:69,598,827...69,616,175
|
|
| G
|
Enpp7
|
ectonucleotide pyrophosphatase/phosphodiesterase 7
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to ENPP7 protein
|
CTD |
PMID:27129696 |
|
NCBI chr10:104,740,763...104,745,760
Ensembl chr10:104,740,763...104,745,760
|
|
| G
|
Flrt3
|
fibronectin leucine rich transmembrane protein 3
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to FLRT3 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 3:148,448,115...148,461,458
Ensembl chr 3:148,439,354...148,461,650
|
|
| G
|
Fn1
|
fibronectin 1
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to FN1 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
increases expression multiple interactions
|
ISO
|
Fluorescein-5-isothiocyanate results in increased expression of HMOX1 protein [Melatonin co-treated with diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased expression of HMOX1 protein
|
CTD |
PMID:27871981 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to HSPA5 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Hspa9
|
heat shock protein family A (Hsp70) member 9
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to HSPA9 protein
|
CTD |
PMID:27129696 |
|
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398
|
|
| G
|
Ifng
|
interferon gamma
|
multiple interactions decreases expression
|
ISO
|
[Dibutyl Phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IFNG protein; [Fluorescein-5-isothiocyanate co-treated with tributyrin] results in increased secretion of IFNG protein; [Fluorescein-5-isothiocyanate co-treated with tricaproin] results in increased secretion of IFNG protein; [tributyrin co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IFNG protein; pyrrolidine dithiocarbamic acid inhibits the reaction [Fluorescein-5-isothiocyanate results in decreased expression of IFNG protein]
|
CTD |
PMID:27863430 PMID:29198882 PMID:36870414 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Ikbkb
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to IKBKB protein
|
CTD |
PMID:27129696 |
|
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
|
|
| G
|
Ikzf4
|
IKAROS family zinc finger 4
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to IKZF4 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 7:1,643,379...1,687,524
Ensembl chr 7:1,644,799...1,687,094
|
|
| G
|
Il13
|
interleukin 13
|
multiple interactions increases expression
|
ISO
|
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL13 protein]]; diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL13 protein]
|
CTD |
PMID:28240277 |
|
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483
|
|
| G
|
Il17a
|
interleukin 17A
|
multiple interactions
|
ISO
|
[Fluorescein-5-isothiocyanate co-treated with tributyrin] results in increased secretion of IL17A protein
|
CTD |
PMID:36870414 |
|
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
|
|
| G
|
Il17re
|
interleukin 17 receptor E
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to IL17RE protein
|
CTD |
PMID:27129696 |
|
NCBI chr 4:148,160,384...148,173,830
Ensembl chr 4:148,159,475...148,173,827
|
|
| G
|
Il31ra
|
interleukin 31 receptor A
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to IL31RA protein
|
CTD |
PMID:27129696 |
|
NCBI chr 2:45,851,073...45,922,300
Ensembl chr 2:45,855,868...45,917,009
|
|
| G
|
Il4
|
interleukin 4
|
multiple interactions increases expression
|
ISO
|
[Dibutyl Phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IL4 protein; [dibutyrylglycerol analog co-treated with Fluorescein-5-isothiocyanate] affects the secretion of IL4 protein; [Fluorescein-5-isothiocyanate co-treated with tributyrin] results in increased secretion of IL4 protein; [Fluorescein-5-isothiocyanate co-treated with tricaproin] results in increased secretion of IL4 protein; [tributyrin co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IL4 protein; diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL4 protein]; diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL4 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL4 protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL4 protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL4 protein]
|
CTD |
PMID:27863430 PMID:27871981 PMID:29198882 PMID:36870414 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il5
|
interleukin 5
|
increases expression multiple interactions
|
ISO
|
Fluorescein-5-isothiocyanate results in increased expression of IL5 protein diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL5 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL5 protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL5 protein]
|
CTD |
PMID:27863430 |
|
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions increases expression
|
ISO
|
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL6 protein]]; diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL6 protein]
|
CTD |
PMID:28240277 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Lypd3
|
Ly6/Plaur domain containing 3
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to LYPD3 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 1:89,354,354...89,358,806
Ensembl chr 1:89,354,335...89,358,810
|
|
| G
|
Maff
|
MAF bZIP transcription factor F
|
increases expression
|
ISO
|
Fluorescein-5-isothiocyanate results in increased expression of MAFF mRNA
|
CTD |
PMID:20491607 |
|
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147
|
|
| G
|
Map3k20
|
mitogen-activated protein kinase kinase kinase 20
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to MAP3K20 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 3:77,538,146...77,697,540
Ensembl chr 3:77,537,956...77,697,538
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
increases phosphorylation multiple interactions
|
ISO
|
Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK1 protein Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK1 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:27129696 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
increases phosphorylation multiple interactions
|
ISO
|
Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK3 protein Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK3 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:27129696 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions increases phosphorylation
|
ISO
|
Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK8 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein] Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK8 protein
|
CTD |
PMID:27129696 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
multiple interactions increases phosphorylation
|
ISO
|
Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK9 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK9 protein
|
CTD |
PMID:27129696 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Mt2
|
metallothionein 2
|
increases expression
|
ISO
|
Fluorescein-5-isothiocyanate results in increased expression of MT2A mRNA
|
CTD |
PMID:20491607 |
|
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709
|
|
| G
|
Mybpc1
|
myosin binding protein C1
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to MYBPC1 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 7:24,817,770...24,903,681
Ensembl chr 7:24,817,561...24,903,544
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions
|
ISO
|
[Melatonin co-treated with diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased expression of NFE2L2 protein
|
CTD |
PMID:27871981 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
increases expression multiple interactions
|
ISO
|
Fluorescein-5-isothiocyanate results in increased expression of NQO1 mRNA Fluorescein-5-isothiocyanate results in increased expression of NQO1 protein diisodecyl phthalate inhibits the reaction [Fluorescein-5-isothiocyanate results in increased expression of NQO1 protein]; Melatonin inhibits the reaction [diisodecyl phthalate inhibits the reaction [Fluorescein-5-isothiocyanate results in increased expression of NQO1 protein]]
|
CTD |
PMID:20491607 PMID:27871981 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Plce1
|
phospholipase C, epsilon 1
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to PLCE1 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 1:245,655,855...245,964,966
Ensembl chr 1:245,657,080...245,963,828
|
|
| G
|
Postn
|
periostin
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to POSTN protein
|
CTD |
PMID:27129696 |
|
NCBI chr 2:140,677,774...140,709,304
Ensembl chr 2:140,677,754...140,709,300
|
|
| G
|
Pprc1
|
PPARG related coactivator 1
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to PPRC1 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 1:254,851,136...254,867,570
Ensembl chr 1:254,851,164...254,867,570
|
|
| G
|
Prkcb
|
protein kinase C, beta
|
increases expression
|
ISO
|
Fluorescein-5-isothiocyanate results in increased expression of PRKCB protein
|
CTD |
PMID:31958493 |
|
NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:186,263,447...186,594,740
|
|
| G
|
Psd4
|
pleckstrin and Sec7 domain containing 4
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to PSD4 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 3:27,535,341...27,571,850
Ensembl chr 3:27,535,440...27,573,731
|
|
| G
|
Psmd14
|
proteasome 26S subunit, non-ATPase 14
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to PSMD14 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 3:66,662,933...66,755,666
Ensembl chr 3:66,662,900...66,755,665
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions increases phosphorylation
|
ISO
|
[2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide co-treated with diisononyl phthalate] promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of RELA protein]; [diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased phosphorylation of RELA protein; diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of RELA protein]; Melatonin inhibits the reaction [[diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased phosphorylation of RELA protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of RELA protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of RELA protein]
|
CTD |
PMID:27863430 PMID:27871981 PMID:28240277 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Scn5a
|
sodium voltage-gated channel alpha subunit 5
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to SCN5A protein
|
CTD |
PMID:27129696 |
|
NCBI chr 8:128,098,613...128,196,515
Ensembl chr 8:128,098,613...128,196,470
|
|
| G
|
Skor1
|
SKI family transcriptional corepressor 1
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to SKOR1 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 8:72,494,554...72,505,127
Ensembl chr 8:72,494,566...72,503,460
|
|
| G
|
Slc10a1
|
solute carrier family 10 member 1
|
multiple interactions increases uptake
|
ISO
|
Taurocholic Acid promotes the reaction [SLC10A1 protein results in increased uptake of Fluorescein-5-isothiocyanate]
|
CTD |
PMID:32209977 |
|
NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944
|
|
| G
|
Slc38a10
|
solute carrier family 38, member 10
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to SLC38A10 protein
|
CTD |
PMID:27129696 |
|
NCBI chr10:105,885,250...105,935,043
Ensembl chr10:105,885,250...105,935,043
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
multiple interactions increases phosphorylation
|
ISO
|
diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT3 protein]; diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT3 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT3 protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT3 protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT3 protein]
|
CTD |
PMID:27863430 PMID:27871981 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Stat5a
|
signal transducer and activator of transcription 5A
|
multiple interactions increases phosphorylation
|
ISO
|
diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT5 protein]; diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT5 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT5 protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT5 protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT5 protein]
|
CTD |
PMID:27863430 PMID:27871981 |
|
NCBI chr10:86,285,859...86,310,187
Ensembl chr10:86,285,547...86,310,184
|
|
| G
|
Stat6
|
signal transducer and activator of transcription 6
|
increases phosphorylation multiple interactions
|
ISO
|
Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT6 protein diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT6 protein]; diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT6 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT6 protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT6 protein]]
|
CTD |
PMID:27863430 PMID:27871981 |
|
NCBI chr 7:65,365,505...65,382,825
Ensembl chr 7:65,365,306...65,383,795
|
|
| G
|
Tpsab1
|
tryptase alpha/beta 1
|
multiple interactions increases expression
|
ISO
|
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TPSAB1 protein]]; diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TPSAB1 protein]
|
CTD |
PMID:28240277 |
|
NCBI chr10:14,864,887...14,867,302
Ensembl chr10:14,864,887...14,867,302
|
|
| G
|
Trpa1
|
transient receptor potential cation channel, subfamily A, member 1
|
affects binding increases expression multiple interactions
|
ISO
|
Fluorescein-5-isothiocyanate binds to TRPA1 protein Fluorescein-5-isothiocyanate results in increased expression of TRPA1 mRNA; Fluorescein-5-isothiocyanate results in increased expression of TRPA1 protein 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 mRNA]]; 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 protein]]; diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 mRNA]; diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 mRNA]]; pyrrolidine dithiocarbamic acid inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 protein]]
|
CTD |
PMID:27129696 PMID:28240277 |
|
NCBI chr 5:9,163,060...9,217,325
Ensembl chr 5:9,163,060...9,217,325
|
|
| G
|
Tslp
|
thymic stromal lymphopoietin
|
increases expression multiple interactions
|
ISO
|
Fluorescein-5-isothiocyanate results in increased expression of TSLP protein [2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide co-treated with diisononyl phthalate] promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TSLP protein]; diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TSLP protein]; diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TSLP protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TSLP protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TSLP protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [Fluorescein-5-isothiocyanate results in increased expression of TSLP protein]
|
CTD |
PMID:27863430 PMID:27871981 PMID:28240277 |
|
NCBI chr18:24,723,990...24,728,419
Ensembl chr18:24,720,257...24,728,420
|
|
| G
|
Txn1
|
thioredoxin 1
|
increases expression
|
ISO
|
Fluorescein-5-isothiocyanate results in increased expression of TXN mRNA
|
CTD |
PMID:20491607 |
|
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307
|
|
| G
|
Usp3
|
ubiquitin specific peptidase 3
|
affects binding
|
ISO
|
Fluorescein-5-isothiocyanate binds to USP3 protein
|
CTD |
PMID:27129696 |
|
NCBI chr 8:75,973,278...76,049,151
Ensembl chr 8:75,974,615...76,049,153
|
|
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
increases transport
|
ISO
|
ABCB1 protein results in increased transport of N-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine
|
CTD |
PMID:21436125 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
|
|
| G
|
Acp2
|
acid phosphatase 2, lysosomal
|
affects expression multiple interactions
|
ISO
|
pyrene affects the expression of ACP2 protein [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of ACP2 protein
|
CTD |
PMID:28803881 |
|
NCBI chr 3:97,630,654...97,642,601
Ensembl chr 3:97,631,326...97,642,565
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions increases activity affects response to substance affects binding
|
EXP ISO
|
pyrene binds to and results in increased activity of AHR protein; pyrene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein] [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene co-treated with pyrene] results in increased activity of AHR protein; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [indeno(1,2,3-cd)pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene] promotes the reaction [pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with pyrene] promotes the reaction [fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [chrysene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benzo(k)fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benzo(j)fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; [Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benz(a)anthracene results in increased activity of AHR protein]; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein; [pyrene co-treated with Benzo(a)pyrene] results in increased activity of AHR protein; [pyrene co-treated with Benzo(a)pyrene] results in increased expression of AHR mRNA; [pyrene co-treated with naphthalene] inhibits the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; [pyrene co-treated with phenanthrene] inhibits the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein]; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; fluoranthene promotes the reaction [pyrene results in increased activity of AHR protein]; pyrene promotes the reaction [fluoranthene results in increased activity of AHR protein] AHR affects the susceptibility to pyrene [AHR affects the susceptibility to pyrene] which affects the expression of UGT1A1 mRNA; [AHR affects the susceptibility to pyrene] which affects the expression of UGT1A6A mRNA; [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of AHR mRNA; AHR gene mutant form promotes the reaction [pyrene results in increased expression of NR1I3 mRNA] pyrene binds to AHR protein
|
CTD |
PMID:3024361 PMID:12850102 PMID:17618724 PMID:17665671 PMID:28710019 PMID:29502740 PMID:30980910 PMID:33249052 PMID:37888695 More...
|
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Ahrr
|
aryl-hydrocarbon receptor repressor
|
multiple interactions
|
ISO
|
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHRR protein; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein]
|
CTD |
PMID:28710019 PMID:30980910 |
|
NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866
|
|
| G
|
Aldh3a1
|
aldehyde dehydrogenase 3 family, member A1
|
decreases expression
|
ISO
|
pyrene results in decreased expression of ALDH3A1 mRNA
|
CTD |
PMID:32890658 |
|
NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151
|
|
| G
|
Ar
|
androgen receptor
|
multiple interactions
|
ISO
|
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein]; pyrene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; pyrene inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; pyrene inhibits the reaction [Metribolone results in increased activity of AR protein]
|
CTD |
PMID:18324785 PMID:26022396 PMID:30980910 PMID:33049310 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Arnt
|
aryl hydrocarbon receptor nuclear translocator
|
multiple interactions
|
ISO
|
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of ARNT protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of ARNT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ARNT mRNA
|
CTD |
PMID:28710019 |
|
NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions affects expression
|
ISO
|
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of BAX protein pyrene affects the expression of BAX protein
|
CTD |
PMID:28803881 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Casp3
|
caspase 3
|
increases expression multiple interactions increases activity
|
EXP ISO
|
pyrene results in increased expression of CASP3 mRNA pyrene inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein] pyrene results in increased activity of CASP3 protein pyrene results in increased expression of CASP3 protein [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CASP3 protein
|
CTD |
PMID:19815060 PMID:28803881 PMID:31368503 PMID:35908932 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp7
|
caspase 7
|
increases activity
|
EXP
|
pyrene results in increased activity of CASP7 protein
|
CTD |
PMID:31368503 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
|
|
| G
|
Ccna2
|
cyclin A2
|
multiple interactions decreases expression
|
ISO
|
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in decreased expression of CCNA2 protein pyrene results in decreased expression of CCNA2 protein
|
CTD |
PMID:28803881 |
|
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
|
|
| G
|
Ccnd1
|
cyclin D1
|
multiple interactions increases expression
|
ISO
|
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CCND1 protein pyrene results in increased expression of CCND1 protein
|
CTD |
PMID:28803881 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Cd63
|
Cd63 molecule
|
decreases expression
|
EXP
|
pyrene results in decreased expression of CD63 protein
|
CTD |
PMID:31368503 |
|
NCBI chr 7:1,909,538...1,924,937
Ensembl chr 7:1,922,169...1,924,938
|
|
| G
|
Cd81
|
Cd81 molecule
|
decreases expression
|
EXP
|
pyrene results in decreased expression of CD81 protein
|
CTD |
PMID:31368503 |
|
NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:207,664,885...207,681,092
|
|
| G
|
Cdk2
|
cyclin dependent kinase 2
|
multiple interactions increases expression
|
ISO
|
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CDK2 protein pyrene results in increased expression of CDK2 protein
|
CTD |
PMID:28803881 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
|
|
| G
|
Comt
|
catechol-O-methyltransferase
|
multiple interactions
|
ISO
|
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of COMT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of and affects the activity of COMT protein
|
CTD |
PMID:28710019 |
|
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533
|
|
| G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
multiple interactions affects expression
|
ISO
|
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of CYP19A1 protein pyrene affects the expression of CYP19A1 protein
|
CTD |
PMID:28803881 |
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
multiple interactions decreases expression increases expression increases activity increases hydroxylation
|
ISO EXP
|
[Docosahexaenoic Acids co-treated with pyrene] results in decreased expression of CYP1A1 mRNA; [fluoranthene co-treated with pyrene] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein; [phenanthrene co-treated with pyrene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with dibenzo(a,l)pyrene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A1 mRNA; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein]; pyrene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA] pyrene results in decreased expression of CYP1A1 mRNA pyrene results in increased expression of CYP1A1 mRNA; pyrene results in increased expression of CYP1A1 protein [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A1 mRNA pyrene results in increased activity of CYP1A1 protein CYP1A1 protein results in increased hydroxylation of pyrene
|
CTD |
PMID:7750161 PMID:15016593 PMID:15566942 PMID:16906435 PMID:25956473 PMID:26160115 PMID:28710019 PMID:30240548 PMID:30980910 PMID:32890658 PMID:33249052 More...
|
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
increases hydroxylation increases expression multiple interactions
|
ISO EXP
|
CYP1A2 protein results in increased hydroxylation of pyrene pyrene results in increased expression of CYP1A2 mRNA pyrene results in increased expression of CYP1A2 mRNA; pyrene results in increased expression of CYP1A2 protein [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA; pyrene results in increased expression of and results in increased activity of CYP1A2 protein
|
CTD |
PMID:7750161 PMID:15016593 PMID:17618724 PMID:26160115 PMID:30240548 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
increases hydroxylation multiple interactions decreases expression increases expression
|
ISO
|
CYP1B1 protein results in increased hydroxylation of pyrene pyrene inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1B1 protein] pyrene results in decreased expression of CYP1B1 mRNA pyrene results in increased expression of CYP1B1 protein [phenanthrene co-treated with pyrene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with dibenzo(a,l)pyrene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1B1 mRNA; pyrene binds to and results in decreased activity of CYP1B1 protein; pyrene inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]
|
CTD |
PMID:15016593 PMID:15566942 PMID:19365803 PMID:19563207 PMID:30248327 PMID:32890658 PMID:35908932 More...
|
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
| G
|
Cyp2b1
|
cytochrome P450, family 2, subfamily b, polypeptide 1
|
increases expression
|
EXP
|
pyrene results in increased expression of CYP2B1 mRNA
|
CTD |
PMID:30240548 |
|
NCBI chr 1:90,646,098...90,669,762
|
|
| G
|
Cyp2b2
|
cytochrome P450, family 2, subfamily b, polypeptide 2
|
increases expression
|
EXP
|
pyrene results in increased expression of CYP2B2 mRNA
|
CTD |
PMID:30240548 |
|
NCBI chr 1:90,722,243...90,736,272
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
increases expression multiple interactions
|
ISO
|
pyrene results in increased expression of CYP2B6 mRNA pyrene results in increased expression of CYP2B10 mRNA NR1I3 gene mutant form inhibits the reaction [pyrene results in increased expression of CYP2B10 mRNA] [fluoranthene co-treated with Benzo(a)pyrene] inhibits the reaction [pyrene results in increased expression of CYP2B6 mRNA]; [pyrene co-treated with Benzo(a)pyrene] inhibits the reaction [fluoranthene results in increased expression of CYP2B6 mRNA]; [pyrene co-treated with fluoranthene] results in increased expression of CYP2B6 mRNA; [pyrene results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA; Benzo(a)pyrene inhibits the reaction [pyrene results in increased expression of CYP2B6 mRNA]
|
CTD |
PMID:17618724 PMID:26160115 PMID:33249052 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Cyp2c11
|
cytochrome P450, subfamily 2, polypeptide 11
|
affects expression
|
EXP
|
pyrene affects the expression of CYP2C11 mRNA
|
CTD |
PMID:30240548 |
|
NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:246,174,711...246,211,853
|
|
| G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
affects expression
|
EXP
|
pyrene affects the expression of CYP2C6 mRNA
|
CTD |
PMID:30240548 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
decreases expression
|
EXP
|
pyrene results in decreased expression of CYP2E1 mRNA
|
CTD |
PMID:30240548 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Cyp3a23-3a1
|
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
|
increases expression
|
EXP
|
pyrene results in increased expression of CYP3A23-3A1 mRNA
|
CTD |
PMID:30240548 |
|
NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein]; pyrene binds to and results in increased activity of ESR1 protein
|
CTD |
PMID:30980910 PMID:33049310 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esr2
|
estrogen receptor 2
|
multiple interactions
|
ISO
|
pyrene binds to and results in increased activity of ESR2 protein
|
CTD |
PMID:33049310 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Gjb1
|
gap junction protein, beta 1
|
decreases expression
|
EXP
|
pyrene results in decreased expression of GJB1 protein
|
CTD |
PMID:25268939 |
|
NCBI chr X:70,541,845...70,549,776
Ensembl chr X:70,541,862...70,549,843
|
|
| G
|
Gsta1
|
glutathione S-transferase alpha 1
|
decreases expression
|
ISO
|
pyrene results in decreased expression of GSTA1 mRNA
|
CTD |
PMID:32890658 |
|
NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528
|
|
| G
|
Gstm1
|
glutathione S-transferase mu 1
|
multiple interactions increases expression
|
ISO
|
[Docosahexaenoic Acids co-treated with pyrene] results in decreased expression of GSTM1 protein pyrene results in increased expression of GSTM1 mRNA
|
CTD |
PMID:25956473 PMID:26160115 |
|
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
|
|
| G
|
Gstm5
|
glutathione S-transferase, mu 5
|
increases expression
|
ISO
|
pyrene results in increased expression of GSTM3 mRNA
|
CTD |
PMID:26160115 |
|
NCBI chr 2:198,219,769...198,222,732
Ensembl chr 2:198,219,647...198,222,731
|
|
| G
|
H2ax
|
H2A.X variant histone
|
multiple interactions
|
ISO
|
[pyrene co-treated with Benzo(a)pyrene] results in increased expression of H2AX protein; [pyrene co-treated with fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of H2AX protein
|
CTD |
PMID:33249052 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
increases expression
|
ISO
|
pyrene results in increased expression of HSPA1A mRNA
|
CTD |
PMID:22367790 |
|
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
increases expression multiple interactions
|
ISO
|
pyrene results in increased expression of ICAM1 protein [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ICAM1 mRNA; [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ICAM1 protein
|
CTD |
PMID:22313677 PMID:37888695 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Ifng
|
interferon gamma
|
affects activity multiple interactions
|
ISO
|
pyrene affects the activity of IFNG protein [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of IFNG protein
|
CTD |
PMID:9258441 PMID:37888695 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO
|
[phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of IL1B protein
|
CTD |
PMID:37888695 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il4
|
interleukin 4
|
increases expression
|
ISO
|
pyrene results in increased expression of IL4 mRNA; pyrene results in increased expression of IL4 protein
|
CTD |
PMID:10756232 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions
|
ISO
|
[phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of IL6 protein
|
CTD |
PMID:37888695 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions
|
ISO
|
[phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of NFE2L2 mRNA
|
CTD |
PMID:37888695 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfkb2
|
nuclear factor kappa B subunit 2
|
multiple interactions
|
ISO
|
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of NFKB2 protein
|
CTD |
PMID:30980910 |
|
NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
increases activity
|
EXP
|
pyrene results in increased activity of NQO1 protein
|
CTD |
PMID:16906435 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
multiple interactions
|
ISO
|
pyrene binds to and results in increased activity of NR1I2 protein
|
CTD |
PMID:33049310 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
| G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
multiple interactions increases expression decreases expression increases activity increases response to substance
|
ISO EXP
|
AHR gene mutant form promotes the reaction [pyrene results in increased expression of NR1I3 mRNA]; NR1I3 gene mutant form inhibits the reaction [pyrene results in decreased abundance of Glutathione]; NR1I3 gene mutant form inhibits the reaction [pyrene results in increased expression of CYP2B10 mRNA]; pyrene affects the localization of and results in increased activity of NR1I3 protein pyrene results in decreased expression of NR1I3 mRNA pyrene results in increased activity of NR1I3 protein NR1I3 results in increased susceptibility to pyrene [Benzo(a)pyrene co-treated with fluoranthene] inhibits the reaction [pyrene results in increased expression of NR1I3 mRNA]; [Benzo(a)pyrene co-treated with pyrene] inhibits the reaction [fluoranthene results in increased expression of NR1I3 mRNA]; [pyrene results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA; Benzo(a)pyrene inhibits the reaction [pyrene results in increased expression of NR1I3 mRNA]; fluoranthene inhibits the reaction [pyrene results in increased expression of NR1I3 mRNA]; pyrene inhibits the reaction [fluoranthene results in increased expression of NR1I3 mRNA]
|
CTD |
PMID:17618724 PMID:26160115 PMID:28927721 PMID:30240548 PMID:33249052 |
|
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases cleavage
|
ISO
|
pyrene results in increased cleavage of PARP1 protein
|
CTD |
PMID:21132278 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pdcd6ip
|
programmed cell death 6 interacting protein
|
increases expression
|
EXP
|
pyrene results in increased expression of PDCD6IP protein
|
CTD |
PMID:31368503 |
|
NCBI chr 8:122,469,223...122,524,993
Ensembl chr 8:122,469,223...122,524,993
|
|
| G
|
Pgr
|
progesterone receptor
|
multiple interactions
|
ISO
|
pyrene inhibits the reaction [16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione results in increased activity of PGR protein]
|
CTD |
PMID:26022396 |
|
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
|
|
| G
|
Piga
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
increases mutagenesis
|
EXP
|
pyrene results in increased mutagenesis of PIGA
|
CTD |
PMID:22923490 |
|
NCBI chr X:33,672,832...33,687,747
Ensembl chr X:33,674,923...33,687,636
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
multiple interactions
|
ISO
|
pyrene binds to and results in increased activity of PPARG protein
|
CTD |
PMID:33049310 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
ISO
|
[Docosahexaenoic Acids co-treated with pyrene] results in increased expression of PTGS2 mRNA
|
CTD |
PMID:25956473 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
[phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of RELA mRNA
|
CTD |
PMID:37888695 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Sele
|
selectin E
|
multiple interactions
|
ISO
|
[phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of SELE mRNA
|
CTD |
PMID:37888695 |
|
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903
|
|
| G
|
Tlr3
|
toll-like receptor 3
|
multiple interactions
|
ISO
|
[Poly I-C binds to TLR3 protein] which affects the susceptibility to pyrene
|
CTD |
PMID:23458896 |
|
NCBI chr16:53,554,916...53,572,321
Ensembl chr16:53,555,131...53,568,385
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO
|
TNF protein promotes the reaction [pyrene results in increased expression of CXCL8 mRNA] [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of TNF protein
|
CTD |
PMID:18434080 PMID:37888695 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tp53
|
tumor protein p53
|
multiple interactions increases expression
|
ISO
|
pyrene inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of TRP53 protein]; pyrene promotes the reaction [Benzo(a)pyrene results in increased expression of TRP53 protein]
|
CTD |
PMID:22120587 PMID:35908932 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Tsg101
|
tumor susceptibility 101
|
increases expression
|
EXP
|
pyrene results in increased expression of TSG101 protein
|
CTD |
PMID:31368503 |
|
NCBI chr 1:106,549,035...106,578,859
Ensembl chr 1:106,535,021...106,578,775
|
|
| G
|
Ugt1a1
|
UDP glucuronosyltransferase family 1 member A1
|
multiple interactions
|
ISO
|
[AHR affects the susceptibility to pyrene] which affects the expression of UGT1A1 mRNA
|
CTD |
PMID:17618724 |
|
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
| G
|
Ugt1a6a
|
UDP glucuronosyltransferase family 1 member A6a
|
multiple interactions
|
ISO
|
[phenanthrene co-treated with pyrene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with dibenzo(a,l)pyrene co-treated with benzo(b)fluoranthene] results in increased expression of UGT1A6 mRNA [AHR affects the susceptibility to pyrene] which affects the expression of UGT1A6A mRNA
|
CTD |
PMID:15566942 PMID:17618724 |
|
NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
| G
|
Vcam1
|
vascular cell adhesion molecule 1
|
multiple interactions
|
ISO
|
[phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of VCAM1 mRNA; [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of VCAM1 protein
|
CTD |
PMID:37888695 |
|
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
|
|
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
multiple interactions
|
ISO
|
7-hydroxycoumarin inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein]
|
CTD |
PMID:24661945 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Akr1c3
|
aldo-keto reductase family 1, member C3
|
multiple interactions increases expression
|
ISO
|
7-hydroxycoumarin inhibits the reaction [AKR1C3 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal]; 7-hydroxycoumarin inhibits the reaction [AKR1C3 mutant form results in increased susceptibility to Hydrogen Peroxide] 7-hydroxycoumarin results in increased expression of AKR1C3 mRNA; 7-hydroxycoumarin results in increased expression of AKR1C3 protein
|
CTD |
PMID:22964423 PMID:28263721 |
|
NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438
|
|
| G
|
Akr7a2
|
aldo-keto reductase family 7, member A2
|
multiple interactions increases expression
|
ISO
|
7-hydroxycoumarin affects the reaction [AKR7A2 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal] 7-hydroxycoumarin results in increased expression of AKR7A2 mRNA; 7-hydroxycoumarin results in increased expression of AKR7A2 protein
|
CTD |
PMID:22964423 PMID:28263721 PMID:30849339 |
|
NCBI chr 5:156,835,589...156,844,127
Ensembl chr 5:156,835,551...156,844,109
|
|
| G
|
Akr7a3
|
aldo-keto reductase family 7 member A3
|
increases expression
|
ISO
|
7-hydroxycoumarin results in increased expression of AKR7A3 mRNA
|
CTD |
PMID:28263721 |
|
NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153
|
|
| G
|
Atf4
|
activating transcription factor 4
|
decreases expression
|
EXP
|
7-hydroxycoumarin results in decreased expression of ATF4 mRNA
|
CTD |
PMID:34979142 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression multiple interactions
|
ISO EXP
|
7-hydroxycoumarin results in increased expression of BAX protein 7-hydroxycoumarin inhibits the reaction [Glycerol results in increased expression of BAX protein]; bisphenol A diglycidyl ether inhibits the reaction [7-hydroxycoumarin inhibits the reaction [Glycerol results in increased expression of BAX protein]]
|
CTD |
PMID:15964220 PMID:34409680 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
ISO EXP
|
7-hydroxycoumarin results in decreased expression of BCL2 protein 7-hydroxycoumarin inhibits the reaction [Glycerol results in decreased expression of BCL2 protein]; bisphenol A diglycidyl ether inhibits the reaction [7-hydroxycoumarin inhibits the reaction [Glycerol results in decreased expression of BCL2 protein]]
|
CTD |
PMID:15964220 PMID:34409680 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions increases activity
|
EXP ISO
|
7-hydroxycoumarin inhibits the reaction [Glycochenodeoxycholic Acid results in increased activity of CASP3 protein] 7-hydroxycoumarin inhibits the reaction [Palmitic Acid results in increased activity of CASP3 protein] 7-hydroxycoumarin results in increased activity of CASP3 protein
|
CTD |
PMID:34979142 PMID:37704181 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Cat
|
catalase
|
multiple interactions
|
ISO
|
7-hydroxycoumarin inhibits the reaction [Dietary Fats results in decreased activity of CAT protein]
|
CTD |
PMID:24661945 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Ccnd1
|
cyclin D1
|
decreases expression
|
ISO
|
7-hydroxycoumarin results in decreased expression of CCND1 protein
|
CTD |
PMID:11679177 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
increases expression multiple interactions
|
EXP
|
7-hydroxycoumarin results in increased expression of CREB1 mRNA 7-hydroxycoumarin inhibits the reaction [Cisplatin results in decreased expression of CREB1 mRNA]
|
CTD |
PMID:33522649 |
|
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Cygb
|
cytoglobin
|
multiple interactions increases expression
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Cisplatin results in decreased expression of CYGB protein] 7-hydroxycoumarin results in increased expression of CYGB protein
|
CTD |
PMID:33522649 |
|
NCBI chr10:102,376,506...102,386,272
Ensembl chr10:102,376,507...102,386,272
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
multiple interactions
|
ISO
|
[CYP1A2 protein results in increased metabolism of coumarin] which results in increased abundance of 7-hydroxycoumarin
|
CTD |
PMID:34334558 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
multiple interactions
|
ISO
|
7-hydroxycoumarin inhibits the reaction [Dietary Fats results in increased activity of CYP2E1 protein]
|
CTD |
PMID:24661945 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Glycochenodeoxycholic Acid results in increased expression of DDIT3 mRNA]
|
CTD |
PMID:34979142 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Foxo3
|
forkhead box O3
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Cisplatin results in increased expression of FOXO3 mRNA]
|
CTD |
PMID:33522649 |
|
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845
|
|
| G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Cisplatin results in increased expression of HAVCR1 protein]
|
CTD |
PMID:33522649 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268
|
|
| G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein]
|
CTD |
PMID:26995004 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
multiple interactions increases expression
|
EXP
|
[7-hydroxycoumarin co-treated with Palmitic Acid] results in increased expression of HSPA5 mRNA 7-hydroxycoumarin results in increased expression of HSPA5 mRNA
|
CTD |
PMID:34979142 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Ikbkb
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Cisplatin results in increased expression of IKBKB protein]
|
CTD |
PMID:33522649 |
|
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Cisplatin results in increased expression of IL1B protein]
|
CTD |
PMID:33522649 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Streptozocin results in increased expression of IL6 protein]
|
CTD |
PMID:36650709 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Ins1
|
insulin 1
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Streptozocin results in decreased expression of INS1 protein]
|
CTD |
PMID:36650709 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
|
|
| G
|
Jak2
|
Janus kinase 2
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Streptozocin results in increased expression of JAK2 mRNA]; 7-hydroxycoumarin inhibits the reaction [Streptozocin results in increased expression of JAK2 protein]
|
CTD |
PMID:36650709 |
|
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Glycochenodeoxycholic Acid results in increased phosphorylation of MAPK1 protein]; 7-hydroxycoumarin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:34979142 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Glycochenodeoxycholic Acid results in increased phosphorylation of MAPK3 protein]; 7-hydroxycoumarin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:34979142 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Glycochenodeoxycholic Acid results in increased phosphorylation of MAPK8 protein]; 7-hydroxycoumarin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK8 protein]
|
CTD |
PMID:34979142 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mpo
|
myeloperoxidase
|
multiple interactions increases oxidation
|
ISO
|
[4-aminobenzhydrazide results in decreased activity of MPO protein] which affects the susceptibility to 7-hydroxycoumarin MPO protein results in increased oxidation of 7-hydroxycoumarin
|
CTD |
PMID:23994743 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions increases expression
|
ISO EXP
|
7-hydroxycoumarin results in increased expression of and affects the localization of NFE2L2 protein 7-hydroxycoumarin results in increased expression of NFE2L2 mRNA; 7-hydroxycoumarin results in increased expression of NFE2L2 protein 7-hydroxycoumarin inhibits the reaction [Cisplatin results in decreased expression of NFE2L2 mRNA]; 7-hydroxycoumarin inhibits the reaction [Cisplatin results in decreased expression of NFE2L2 protein]
|
CTD |
PMID:28263721 PMID:33522649 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
decreases expression multiple interactions
|
EXP
|
7-hydroxycoumarin results in decreased expression of NFKBIA protein 7-hydroxycoumarin inhibits the reaction [Cisplatin results in decreased expression of NFKBIA protein]
|
CTD |
PMID:33522649 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
multiple interactions increases expression
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Cisplatin results in decreased expression of PPARG mRNA] 7-hydroxycoumarin results in increased expression of PPARG mRNA
|
CTD |
PMID:33522649 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Cisplatin results in increased expression of RELA protein]
|
CTD |
PMID:33522649 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Sirt1
|
sirtuin 1
|
increases expression multiple interactions
|
EXP
|
7-hydroxycoumarin results in increased expression of SIRT1 mRNA 7-hydroxycoumarin inhibits the reaction [Cisplatin results in decreased expression of SIRT1 mRNA]
|
CTD |
PMID:33522649 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Slc22a6
|
solute carrier family 22 member 6
|
increases uptake multiple interactions
|
ISO
|
SLC22A6 protein results in increased uptake of 7-hydroxycoumarin metabolite 7-hydroxycoumarin inhibits the reaction [SLC22A6 protein results in increased uptake of 6-carboxyfluorescein]; 7-hydroxycoumarin metabolite inhibits the reaction [SLC22A6 protein results in increased uptake of 6-carboxyfluorescein]; Probenecid inhibits the reaction [SLC22A6 protein results in increased uptake of 7-hydroxycoumarin metabolite]
|
CTD |
PMID:39481674 |
|
NCBI chr 1:214,951,493...214,960,317
Ensembl chr 1:214,951,867...214,960,311
|
|
| G
|
Slc22a8
|
solute carrier family 22 member 8
|
increases uptake multiple interactions
|
ISO
|
SLC22A8 protein results in increased uptake of 7-hydroxycoumarin metabolite 7-hydroxycoumarin inhibits the reaction [SLC22A8 protein results in increased uptake of 6-carboxyfluorescein]; 7-hydroxycoumarin metabolite inhibits the reaction [SLC22A8 protein results in increased uptake of 6-carboxyfluorescein]; Probenecid inhibits the reaction [SLC22A8 protein results in increased uptake of 7-hydroxycoumarin metabolite]
|
CTD |
PMID:39481674 |
|
NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Streptozocin results in increased expression of STAT3 mRNA]; 7-hydroxycoumarin inhibits the reaction [Streptozocin results in increased expression of STAT3 protein]
|
CTD |
PMID:36650709 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Sult1a1
|
sulfotransferase family 1A member 1
|
increases sulfation
|
ISO EXP
|
SULT1A1 protein results in increased sulfation of 7-hydroxycoumarin
|
CTD |
PMID:11181495 |
|
NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Streptozocin results in increased expression of TGFB1 mRNA]; 7-hydroxycoumarin inhibits the reaction [Streptozocin results in increased expression of TGFB1 protein]
|
CTD |
PMID:36650709 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
EXP
|
7-hydroxycoumarin inhibits the reaction [Cisplatin results in increased expression of TNF protein]; 7-hydroxycoumarin inhibits the reaction [Streptozocin results in increased expression of TNF protein]
|
CTD |
PMID:33522649 PMID:36650709 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Ugt1a6a
|
UDP glucuronosyltransferase family 1 member A6a
|
affects metabolic processing increases metabolic processing
|
EXP
|
UGT1A6 gene polymorphism affects the metabolism of 7-hydroxycoumarin UGT1A6 protein results in increased metabolism of 7-hydroxycoumarin
|
CTD |
PMID:9429234 |
|
NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
| G
|
Ugt1a7c
|
UDP glucuronosyltransferase 1 family, polypeptide A7C
|
increases glucuronidation
|
EXP
|
UGT1A7 protein results in increased glucuronidation of 7-hydroxycoumarin; UGT1A8 protein results in increased glucuronidation of 7-hydroxycoumarin
|
CTD |
PMID:15502008 |
|
NCBI chr 9:96,187,382...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
| G
|
Ugt1a9
|
UDP glucuronosyltransferase family 1 member A9
|
increases glucuronidation
|
ISO
|
UGT1A9 protein results in increased glucuronidation of 7-hydroxycoumarin
|
CTD |
PMID:15044611 |
|
NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
| G
|
Ugt2b15
|
UDP glucuronosyltransferase family 2 member B15
|
increases metabolic processing
|
EXP
|
UGT2B15 protein results in increased metabolism of 7-hydroxycoumarin
|
CTD |
PMID:7574722 |
|
NCBI chr14:21,122,866...21,138,450
Ensembl chr14:21,122,861...21,138,467
|
|